United Therapeutics Corp (UTHR) — 8-K Filings

8-K Filings (10)

• UNITED THERAPEUTICS Corp Files 8-K — Mar 30, 2026 Risk: low
  On March 30, 2026, UNITED THERAPEUTICS Corp filed an 8-K report detailing other events and financial statements. The filing includes exhibits such as financial
• United Therapeutics Files 8-K Report — Sep 2, 2025 Risk: low
  On September 2, 2025, United Therapeutics Corporation filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits,"
• United Therapeutics Corp Files 8-K — Aug 1, 2025 Risk: low
  On August 1, 2025, United Therapeutics Corporation entered into a material definitive agreement. The filing also includes information regarding Regulation FD di
• United Therapeutics Files 8-K: Board, Officer, and Compensation Updates — Jun 27, 2025 Risk: low
  On June 26, 2025, United Therapeutics Corporation filed an 8-K report detailing several key events. The company announced the election of new directors and the
• United Therapeutics Corp Files 8-K with Material Agreements — Apr 28, 2025 Risk: medium
  On April 25, 2025, United Therapeutics Corporation entered into a material definitive agreement and simultaneously terminated another. The company also created
• United Therapeutics Files 8-K — Jan 13, 2025 Risk: low
  United Therapeutics Corporation filed an 8-K on January 13, 2025, reporting under Regulation FD and including financial statements and exhibits. The filing deta
• United Therapeutics Approves New Equity Incentive Plan — Jun 27, 2024 Risk: low
  United Therapeutics Corporation announced on June 26, 2024, that its Board of Directors has approved a new equity incentive award plan. This plan allows for the
• United Therapeutics Enters New Loan Agreement — Mar 29, 2024 Risk: medium
  On March 29, 2024, United Therapeutics Corporation entered into a material definitive agreement, specifically a loan agreement. This agreement creates a direct
• United Therapeutics Files 8-K: Material Agreement & Financials — Mar 25, 2024 Risk: medium
  On March 25, 2024, United Therapeutics Corporation filed an 8-K report detailing a material definitive agreement. The filing also included Regulation FD disclos
• United Therapeutics Files 8-K for Undisclosed Event — Feb 27, 2024 Risk: medium
  United Therapeutics Corporation filed an 8-K on February 27, 2024, reporting an "Other Event" that occurred on February 26, 2024. The filing, identified by acce

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX